Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis.
about
Interleukin-1 in the pathogenesis and treatment of inflammatory diseasesPro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study.Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnectChitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemiaThe helminth product ES-62 protects against septic shock via Toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88Performance of severity of illness scoring systems in emergency department patients with infectionThe proinflammatory role of HECTD2 in innate immunity and experimental lung injuryNeutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis modelThe initial Mayo Clinic experience using high-frequency oscillatory ventilation for adult patients: a retrospective study.A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis.Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responsesTherapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens.The evolution of an inflammatory response.Using systems biology to simplify complex disease: immune cartography.A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock.Intestine-specific deletion of microsomal triglyceride transfer protein increases mortality in aged mice.Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African childrenBeneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumoniaMid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational studyModified therapeutic community for co-occurring disorders: single investigator meta analysisHistorical insights into cytokinesEritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies.Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysis.Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis.Critical care medicine in AJRCCM 2002.Recent developments in the treatment of sepsis.Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Anti-inflammatory strategies for the treatment of sepsis.Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality.Interleukin-18 and host defense against infection.The enigma of sepsis.Plasma Neutrophil Gelatinase-Associated Lipocalin Is Primarily Related to Inflammation during Sepsis: A Translational ApproachCharacterization of the interaction of staphylococcal enterotoxin B with CD1d expressed in human renal proximal tubule epithelial cells.Chronic sepsis mortality characterized by an individualized inflammatory responseEfficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock.The association between time to antibiotics and relevant clinical outcomes in emergency department patients with various stages of sepsis: a prospective multi-center study.Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.Pathogenesis of malaria and clinically similar conditions.
P2860
Q24606766-1754B148-50C5-42EC-B4FB-E4A1474D845CQ24802551-A00D62F8-996A-454E-A195-4081A85CAB12Q26996658-7A1A4DD3-E696-4A10-A312-56DBFE340874Q27345437-AA46AD21-711F-44BD-B666-41D2166A95F4Q28115132-6B955CD0-B300-4890-96CB-D778266358F5Q28306781-09796C28-D2E6-4089-AB3E-B06448BBE6EDQ28383410-41A3E708-69C4-44A0-96C2-409DD23032E2Q28572775-04611F88-E865-49D4-8BD7-F474D5426270Q33233347-CB2B201F-2AA2-4FE1-A037-03D6DE4CCD2BQ33305487-B57EDC62-40C7-4335-A162-51ADD94C9FE0Q33338424-27F48195-DF49-48DA-86FF-D479091EE118Q33551373-47B220BE-2670-43F9-99AC-068472D4C104Q33652057-F6585B9C-E757-4FCF-91B1-E867F8DFFDD3Q33762821-DFFE625A-BE20-4806-B0AF-F303FB2BC877Q33828840-0472A5C0-C90E-43D6-A601-2AC230A83179Q33869944-DBB17841-A300-4C12-A795-39060AD242A1Q33882434-AF92D725-7356-4298-9585-EDF8B5AD4C26Q33891519-0AFAA30E-ECCE-48EE-9B00-346981877715Q33965057-AC354570-FCA0-4FDB-80B4-574DC19A052FQ34285366-849ECBAC-4B4C-4D76-9E17-E2B60E18C7DAQ34480748-3A915BD5-3547-41CE-9AAC-77EE25FC404FQ34681868-FAD44617-C7BF-4DFD-891D-ACDD2A4F3574Q34708047-0C821178-AC86-44A2-88D8-DE451C23FFE4Q34726541-E9387441-E0CB-4F74-B0BB-FBB7A4C43B6CQ34866465-EC9AFC4F-2942-4334-81F9-ECAC2A1571B2Q34999316-831BBA5E-5F82-416C-A84A-822CA0299DDCQ35055439-8A0DD5A3-896E-4724-89DB-72939996897CQ35056046-08D677A6-3AC0-47BB-B8D3-18452453F257Q35070866-C085311D-A2B1-4FD0-BDCC-0017B51014D1Q35093632-C50FDA03-DB86-4CA7-B162-72971BEE565EQ35097527-E1B43BC7-0D32-40AA-860F-74533077EC47Q35147841-EE2B13D2-DA55-4632-A9B0-0CB2DBED09D1Q35202458-3488E771-3304-45E8-872F-899A975C4AB6Q35496669-0C5EA507-0F45-4681-AC26-0601C8F65F87Q35554868-7E0CA4F1-6496-4A54-9563-E82AC6128D70Q35600970-5531E8FE-93D0-44AA-B996-F0D9CFC3F9C2Q35624186-237C0A45-23EA-4ACD-92CA-7308F74F0EFDQ35633515-42C3A20B-2E99-4699-A075-E1A65BC55AF5Q35795306-0A09575B-FB4A-4ECB-BD39-6303B477F608Q35838590-864FE517-5F1D-4219-994F-AD0EFE3AB057
P2860
Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Risk and the efficacy of antii ...... onfirmatory studies of sepsis.
@en
Risk and the efficacy of antii ...... onfirmatory studies of sepsis.
@nl
type
label
Risk and the efficacy of antii ...... onfirmatory studies of sepsis.
@en
Risk and the efficacy of antii ...... onfirmatory studies of sepsis.
@nl
prefLabel
Risk and the efficacy of antii ...... onfirmatory studies of sepsis.
@en
Risk and the efficacy of antii ...... onfirmatory studies of sepsis.
@nl
P2093
P1476
Risk and the efficacy of antii ...... onfirmatory studies of sepsis.
@en
P2093
Andre Kalil
Chantal Parent
Charles Natanson
Claire Esposito
Eric P Gerstenberger
Peter Q Eichacker
Robert L Danner
Steven M Banks
Xizhong Cui
Yvonne Fitz
P304
P356
10.1164/RCCM.200204-302OC
P407
P577
2002-11-01T00:00:00Z